DTC - Differentiated Thyroid Cancer
3 clinical trials · Condition
◉ Watch DTC - Differentiated Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer (NCT07287748) | Alpha Fusion Inc. | 2026-01-01 |
| Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment (NCT06405217) | Nanjing First Hospital, Nanjing Medical University | 2024-04-20 |
| Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib (NCT05007093) | Yansong Lin | 2020-12-01 |
Track DTC - Differentiated Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.